Logo image of NCSM

NCS MULTISTAGE HOLDINGS INC (NCSM) Stock Fundamental Analysis

USA - NASDAQ:NCSM - US6288772014 - Common Stock

48.66 USD
+1.66 (+3.53%)
Last: 9/23/2025, 4:04:06 PM
Fundamental Rating

5

Taking everything into account, NCSM scores 5 out of 10 in our fundamental rating. NCSM was compared to 61 industry peers in the Energy Equipment & Services industry. NCSM is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. NCSM is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

In the past year NCSM was profitable.
In the past year NCSM had a positive cash flow from operations.
In the past 5 years NCSM reported 4 times negative net income.
NCSM had a positive operating cash flow in 4 of the past 5 years.
NCSM Yearly Net Income VS EBIT VS OCF VS FCFNCSM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -50M -100M -150M

1.2 Ratios

NCSM has a better Return On Assets (7.98%) than 78.69% of its industry peers.
NCSM has a Return On Equity of 11.84%. This is in the better half of the industry: NCSM outperforms 70.49% of its industry peers.
Looking at the Return On Invested Capital, with a value of 4.85%, NCSM is in line with its industry, outperforming 42.62% of the companies in the same industry.
Industry RankSector Rank
ROA 7.98%
ROE 11.84%
ROIC 4.85%
ROA(3y)0.48%
ROA(5y)-8.68%
ROE(3y)0.67%
ROE(5y)-12.92%
ROIC(3y)N/A
ROIC(5y)N/A
NCSM Yearly ROA, ROE, ROICNCSM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20 -40 -60 -80 -100

1.3 Margins

With a decent Profit Margin value of 7.18%, NCSM is doing good in the industry, outperforming 63.93% of the companies in the same industry.
NCSM's Operating Margin of 4.69% is on the low side compared to the rest of the industry. NCSM is outperformed by 65.57% of its industry peers.
NCSM's Gross Margin of 41.47% is amongst the best of the industry. NCSM outperforms 83.61% of its industry peers.
In the last couple of years the Gross Margin of NCSM has declined.
Industry RankSector Rank
OM 4.69%
PM (TTM) 7.18%
GM 41.47%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.46%
GM growth 5Y-2.64%
NCSM Yearly Profit, Operating, Gross MarginsNCSM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 -60 -80

7

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), NCSM is destroying value.
NCSM has more shares outstanding than it did 1 year ago.
NCSM has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, NCSM has an improved debt to assets ratio.
NCSM Yearly Shares OutstandingNCSM Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500K 1M 1.5M 2M 2.5M
NCSM Yearly Total Debt VS Total AssetsNCSM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

2.2 Solvency

NCSM has an Altman-Z score of 1.08. This is a bad value and indicates that NCSM is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of 1.08, NCSM is not doing good in the industry: 75.41% of the companies in the same industry are doing better.
NCSM has a debt to FCF ratio of 0.85. This is a very positive value and a sign of high solvency as it would only need 0.85 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 0.85, NCSM belongs to the top of the industry, outperforming 83.61% of the companies in the same industry.
NCSM has a Debt/Equity ratio of 0.05. This is a healthy value indicating a solid balance between debt and equity.
With an excellent Debt to Equity ratio value of 0.05, NCSM belongs to the best of the industry, outperforming 83.61% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.05
Debt/FCF 0.85
Altman-Z 1.08
ROIC/WACC0.56
WACC8.73%
NCSM Yearly LT Debt VS Equity VS FCFNCSM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M

2.3 Liquidity

NCSM has a Current Ratio of 4.66. This indicates that NCSM is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of NCSM (4.66) is better than 93.44% of its industry peers.
NCSM has a Quick Ratio of 2.83. This indicates that NCSM is financially healthy and has no problem in meeting its short term obligations.
NCSM's Quick ratio of 2.83 is amongst the best of the industry. NCSM outperforms 88.52% of its industry peers.
Industry RankSector Rank
Current Ratio 4.66
Quick Ratio 2.83
NCSM Yearly Current Assets VS Current LiabilitesNCSM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

5

3. Growth

3.1 Past

NCSM shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 289.17%, which is quite impressive.
The Revenue has grown by 19.31% in the past year. This is quite good.
NCSM shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -4.58% yearly.
EPS 1Y (TTM)289.17%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%133.01%
Revenue 1Y (TTM)19.31%
Revenue growth 3Y11.11%
Revenue growth 5Y-4.58%
Sales Q2Q%22.78%

3.2 Future

NCSM is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 20.41% yearly.
Based on estimates for the next years, NCSM will show a quite strong growth in Revenue. The Revenue will grow by 10.28% on average per year.
EPS Next Y21.34%
EPS Next 2Y20.41%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year13%
Revenue Next 2Y10.28%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
NCSM Yearly Revenue VS EstimatesNCSM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 50M 100M 150M 200M
NCSM Yearly EPS VS EstimatesNCSM Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 -5 -10 -15

6

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 10.42 indicates a reasonable valuation of NCSM.
NCSM's Price/Earnings ratio is rather cheap when compared to the industry. NCSM is cheaper than 90.16% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 27.41, NCSM is valued rather cheaply.
A Price/Forward Earnings ratio of 12.86 indicates a correct valuation of NCSM.
NCSM's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. NCSM is cheaper than 73.77% of the companies in the same industry.
NCSM's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 22.87.
Industry RankSector Rank
PE 10.42
Fwd PE 12.86
NCSM Price Earnings VS Forward Price EarningsNCSM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of NCSM indicates a slightly more expensive valuation: NCSM is more expensive than 63.93% of the companies listed in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of NCSM is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 13.63
EV/EBITDA 7.38
NCSM Per share dataNCSM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60

4.3 Compensation for Growth

NCSM's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
NCSM's earnings are expected to grow with 20.41% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.49
PEG (5Y)N/A
EPS Next 2Y20.41%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

NCSM does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

NCS MULTISTAGE HOLDINGS INC

NASDAQ:NCSM (9/23/2025, 4:04:06 PM)

48.66

+1.66 (+3.53%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryEnergy Equipment & Services
Earnings (Last)07-31 2025-07-31/amc
Earnings (Next)10-28 2025-10-28
Inst Owners15.06%
Inst Owner Change-0.46%
Ins Owners10.84%
Ins Owner Change-0.38%
Market Cap123.60M
Analysts85.71
Price Target41.31 (-15.1%)
Short Float %0.57%
Short Ratio0.41
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)128.53%
Min EPS beat(2)125.74%
Max EPS beat(2)131.31%
EPS beat(4)4
Avg EPS beat(4)82.91%
Min EPS beat(4)15.79%
Max EPS beat(4)131.31%
EPS beat(8)6
Avg EPS beat(8)538.28%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)19.27%
Min Revenue beat(2)9.7%
Max Revenue beat(2)28.84%
Revenue beat(4)4
Avg Revenue beat(4)12.23%
Min Revenue beat(4)0.8%
Max Revenue beat(4)28.84%
Revenue beat(8)6
Avg Revenue beat(8)2.59%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)5.19%
PT rev (3m)5.19%
EPS NQ rev (1m)-2.74%
EPS NQ rev (3m)-15.14%
EPS NY rev (1m)0%
EPS NY rev (3m)50.36%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-2.13%
Revenue NY rev (1m)2.57%
Revenue NY rev (3m)4.43%
Valuation
Industry RankSector Rank
PE 10.42
Fwd PE 12.86
P/S 0.7
P/FCF 13.63
P/OCF 11.77
P/B 1.16
P/tB 1.41
EV/EBITDA 7.38
EPS(TTM)4.67
EY9.6%
EPS(NY)3.78
Fwd EY7.78%
FCF(TTM)3.57
FCFY7.34%
OCF(TTM)4.13
OCFY8.5%
SpS69.08
BVpS41.9
TBVpS34.59
PEG (NY)0.49
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 7.98%
ROE 11.84%
ROCE 6.14%
ROIC 4.85%
ROICexc 5.98%
ROICexgc 7.21%
OM 4.69%
PM (TTM) 7.18%
GM 41.47%
FCFM 5.17%
ROA(3y)0.48%
ROA(5y)-8.68%
ROE(3y)0.67%
ROE(5y)-12.92%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.46%
GM growth 5Y-2.64%
F-Score7
Asset Turnover1.11
Health
Industry RankSector Rank
Debt/Equity 0.05
Debt/FCF 0.85
Debt/EBITDA 0.4
Cap/Depr 25.84%
Cap/Sales 0.82%
Interest Coverage 250
Cash Conversion 76.18%
Profit Quality 71.95%
Current Ratio 4.66
Quick Ratio 2.83
Altman-Z 1.08
F-Score7
WACC8.73%
ROIC/WACC0.56
Cap/Depr(3y)33.2%
Cap/Depr(5y)30.91%
Cap/Sales(3y)1.04%
Cap/Sales(5y)1.16%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)289.17%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%133.01%
EPS Next Y21.34%
EPS Next 2Y20.41%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)19.31%
Revenue growth 3Y11.11%
Revenue growth 5Y-4.58%
Sales Q2Q%22.78%
Revenue Next Year13%
Revenue Next 2Y10.28%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y722.05%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year559.79%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y1077.53%
FCF growth 3Y1.81%
FCF growth 5Y-0.41%
OCF growth 1Y283.25%
OCF growth 3Y3.19%
OCF growth 5Y-6.65%